Skip to main content

US ClosedU.S. Closed

MIRA: MIRA Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase.

52W Range

8thpctl

Volume

0.31×avg

Market Cap

31.52MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

MIRA Pharmaceuticals, Inc.

MIRANASDAQ Capital Market·USD·Closed

MIRA Pharmaceuticals, Inc.

MIRANASDAQ·USD·Closed

$0.75

−2.60%

$0.75

−$0.02 (2.60%)

52W Range

8thpctl

Volume

0.31×avg

Mkt Cap

31.52MUSD

P/E

-0.5TTM

Div Yield

–ann